aod9604 research AOD-9604 5mg AOD9604 - Oath Research
Description
Inform healthcare providers about GHK-Cu use before any procedures Monitor for unusual skin reactions or systemic effects Consider periodic copper and zinc level testing for extended protocols Start with lower doses and increase gradually to assess tolerance Use only pharmaceutical-grade peptides from reputable sources For extended use protocols, periodic laboratory monitoring adds an additional layer of safety

10.1007/s00109-015-1310-2 115 RobertiA.FernndezA

Experimental findings indicate that the compound may trigger cellular mechanisms that release fatty acids from fat stores without significantly altering insulin or IGF-1 levels

[DOI] [PubMed] [Google Scholar] 222.Pinkerton, A
